Cell & Gene Therapy Insights – Trince spotlight
Trince is included in the “Emerging technologies & companies in cell & gene therapy manufacturing” review in the Tools of tomorrow issue of Cell & Gene Therapy insights.
View our latest announcements
Trince is included in the “Emerging technologies & companies in cell & gene therapy manufacturing” review in the Tools of tomorrow issue of Cell & Gene Therapy insights.
We are delighted to welcome Emilie Viey, PhD to the Trince team as our new Chief Commercial Officer.
Together with Revatis, we successfully used our LumiPore transfection platform to deliver macromolecules into equine and human mesenchymal stem cells.
We are proud to announce that Clarivate has included both our scientific co-founders in their prestigious list of Highly Cited Researchers for 2022.
With 82 citations within one year after publication, our Nature Nanotechnology tpaper has received the status of Hot Paper by Web of Science.
We’d love to meet you at one of these events!
Paris, May 31-June 3, 2023
Carlsbad, October 10-12, 2023
Contact us to arrange a meeting
Ottergemsesteenweg Zuid 731 | 9000 Gent | Belgium
Privacy Policy | Terms & Conditions | Cookie policy